| Date | Subject | Details |
|---|---|---|
| 2021/07/15 | Investigation concluded and decision not to prosecute received by former director, alleged to have violated the Securities and Exchange Act | 20210715 |
| 2021/07/14 | The Company’s Board of Directors resolved to change the date of the 2021 general shareholders meeting (According to the “Measures for Public Companies to Postpone Shareholders Meetings in Response to COVID-19 Pandemic” announced by the Financial Supervisory Commission on) | 20210714 |
| 2021/06/25 | Announcement on behalf of the Company’s major subsidiary TBG Diagnostics Ltd. regarding the convention of the general shareholders meeting | 20210625 |
| 2021/06/11 | The Company has submitted the autologous natural killer cell therapy (Magicell-NK) phase 1 clinical trial application to the Taiwan Food and Drug Administration (TFDA) of the Ministry of Health and Welfare (MOHW) | 20210611 |
| 2021/05/20 | The Company has suspended the general shareholders meeting originally scheduled on 2021/06/28 in accordance with the instructions from the Financial Supervisory Commission | 20210520 |
| 2021/05/18 | Taiwan Ministry of Health and Welfare (MOHW) approves the collaborative autologous NK cell therapy project by the Company and the En Chu Kong Hospital | 20210518 |
| 2021/05/11 | The Company’s 2021 Q1 consolidated financial reports has been approved by the resolution of the Board of Directors | 20210511 |
| 2021/05/06 | Update on the progress of the US clinical trial for the investigational new drug OBP-301 in patients with head and neck cancer | 20210506 |
| 2021/04/15 | Taiwan Ministry of Health and Welfare (MOHW) approves the collaborative autologous NK cell therapy project by the Company and the Shin Kong Hospital | 20210415 |
| 2021/04/08 | Taiwan Ministry of Health and Welfare (MOHW) approves the collaborative autologous NK cell therapy project by the Company and the Changhua Christian Hospital | 20210408 |
| 2021/03/25 | The Company has received approval letter from the Taiwan Ministry of Health and Welfare (MOHW) for the joint autologous NK cell therapy project with the Jen-Ai Hospital Dali Branch | 20210325 |
| 2021/03/19 | The Company’s 2020 consolidated financial reports has been approved by the resolution of the Board of Directors | 20210319 |
| 2021/03/19 | The Company’s Board of Directors resolved to convene the 2021 general shareholders meeting | 20210319 |
| 2021/03/19 | The Company has changed the certified public accountant (CPA) due to internal adjustment of the accounting firm | 20210319 |
| 2021/03/19 | The Company’s board of directors resolved not to distribute dividends | 20210319 |
| 2021/02/25 | Investigation concluded and decision not to prosecute received by former director, alleged to have violated the Securities and Exchange Act | 20210225 |
